An artistic depiction of the heart and its vessels.

Penn Medicine at the 2026 American Heart Association’s Scientific Sessions

Penn Medicine faculty will present research on the latest advances in cardiovascular medicine at the 2026 AHA Scientific Sessions in Chicago.

  • October 30, 2026

University of Pennsylvania Perelman School of Medicine faculty will present research on the latest advances in cardiovascular medicine, science, and education at the 2026 American Heart Association’s Scientific Sessions, at McCormick Place Convention Center in Chicago, Illinois from November 6–9, 2026.

Expert interviews

To arrange interviews with any of these presenters or other Penn physicians who will be in attendance and can provide outside comment on other sessions, please call 267-600-4871 or email matthew.toal@pennmedicine.upenn.edu. All research results are embargoed until the time they are presented during the conference. All times listed are Central Standard Time. Please refer to the American Heart Association for embargo policies pertaining to presentations at the Scientific Sessions.

Penn’s Zoltan Arany to receive 2026 Distinguished Scientist Award

Zoltan Arany
Zoltan Arany, MD, PhD

Zoltan Arany, MD, PhD, the Samuel Bellet Professor of Cardiology and chair of the Department of Physiology in the Perelman School of Medicine at the University of Pennsylvania, has been named an American Heart Association Distinguished Scientist for 2026, one of the organization’s highest scientific honors. The award recognizes researchers whose sustained and transformative contributions have advanced the understanding and treatment of cardiovascular disease.

Arany is internationally recognized for his pioneering work in cardiovascular metabolism, helping uncover how changes in the way the heart uses and produces energy contribute to conditions ranging from heart failure to peripartum cardiomyopathy. As director of Penn’s Cardiovascular Metabolism Program, his research has combined molecular biology, genetics, and human studies to reveal new insights into the metabolic mechanisms that drive heart disease and identify potential therapeutic targets.

Arany’s research has fundamentally changed researchers understanding of how metabolism influences cardiovascular health and disease. His work has earned election to the National Academy of Medicine and has resulted in more than 200 peer-reviewed publications in leading scientific journals. He will be recognized at the American Heart Association Scientific Sessions 2026 in Chicago.

Notable presentations by Penn Medicine faculty

Several Penn Medicine researchers and clinicians will participate in this year’s American Heart Association Scientific Sessions. The presentations highlighted below represent a selection of Penn’s contributions; for a comprehensive list of presenters and sessions, visit the AHA Scientific Sessions 2026 website.

Friday, November 6, 2026

10:15 – 10:30 AM

Presentation | Genomics in unsolved arrhythmia

Presenter: Andrew Landstrom, MD, PhD

 

1:00 – 1:05 PM

Presentation | Understanding Cardiovascular-Kidney-Metabolic Risk: Staging and Prevention

Presenter: Chiadi Ndumele, MD

 

5:15 – 5:24 PM

Presentation | Finding Your Mentors and Your Metrics: How to Launch in Cardio-Oncology

Presenter: Nicholas Wilcox, MD

 

Saturday, November 7, 2026

9:45- 10:00 AM

Presentation | Food Is Medicine to Reduce Cardiometabolic Risk: Emerging Evidence and Clinical Promise

Presenter: Kevin Volpp, MD, PhD

 

9:54 - 10:05 AM

Presentation | State of the Art II: Intermediate-Risk PE After HI-PEITHO and Storm PE: Have We Finally Beaten Anticoagulation Alone?

Presenter: Jay Giri, MD, MPH

 

2:00- 2:10 PM

Presentation A Randomized Controlled Trial of Spironolactone-Based Blood Pressure Management After Stroke

Presenter: Jordana Cohen, MD, MSCE

 

2:15 – 2:25 PM

Presentation | Genetic Lipidomic Analyses Reveal Specific Circulating Lipids as Potentially Causal Risk Factors for Aortic Stenosis in Contrast with Coronary Artery Disease

Presenter: Guoyi Yang, PhD

 

2:18 – 2:25 PM

Guidelines Presentation | Catheter-Based Therapies for PE: Patient Selection, Devices, and Guideline Integration

Presenter: Jay Giri, MD, MPH

 

Sunday, November 8, 2026

9:29 – 9:34 AM

Presentation | Growth Differentiation Factor-15 and Longitudinal Cardiac Function Following Breast Cancer Therapy

Presenter: Nicholas Wilcox, MD

 

3:15- 4:15 PM

Presentation | Genetic Reduction in Angiopoietin-Like Proteins 3 and 4 Exerts Distinct Effects on Cardiovascular Disease Risk Through Differential Enhancement of Lipase Activities

Presenter: Guoyi Yang, PhD

Media contact

Matt Toal
C: 267-600-4871
Matthew.Toal@pennmedicine.upenn.edu

For Media Queries & Requests (24/7): 215-662-2560

Follow us

Related articles

$25 million gift establishes Smilow precision center

The Smilow Foundation’s gift will advance gene editing and other precision therapies for cardiovascular disease.

  • October 8, 2026

How a leading class of heart failure drugs powers the heart

Researchers have discovered that SGLT2 inhibitors work by activating a key enzyme that helps heart cells produce and use energy more efficiently.

  • August 27, 2026

Subscribe

Subscribe to Penn Medicine newsletters and publications for the latest developments.